PHAR

Pharming Group N.V.

HealthcareBiotechnologyNLUSDCountry macro →

$12.87

LiveJun 01, 2026

Market cap

$909.11M

52w range

9.54 – 21.34

P / E

—

EPS

—

Volume

8.98K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Pharming Group N.V.’s valuation

Composite rating

—

Consensus

—

Target consensus

—

Recent activity

—

Last 30 days

No ratings snapshot in DB for this symbol yet.

No grades consensus available.

Green = best, red = worst (per column)

Ticker	Mcap	P/E	P/S	EV/EBITDA	ROE	D/E	Div Yield
PHARPharming Group N.V.Focus	—	—	—	—	—	—	—

Stacked monthly counts

No analyst-grade actions in analyst_grades for PHAR over the last 5 years.